Some preclinical studies say that cannabidiol (CBD) can have therapeutic properties on opiates, cocaine and psychostimulant addiction. They also suggest that CBD may be beneficial for the consumption of cannabis and tobacco in humans. However, more studies are needed to fully verify the potential of the CBD. View study
Cannabis as a substitute for alcohol and other drugs. (2009).
This study was conducted based on data collected in an anonymous survey to examine the use of alcohol and drugs, and the occurrence of substitution among medicinal cannabis patients. It was found that the reasons for the substitution were: fewer adverse side effects (65%), better management of symptoms (57%) and less potential for abstinence (34%) with cannabis. As a result of this study it was found that medicinal cannabis patients have been participating in the substitution using cannabis as an alternative to alcohol, prescriptions and illicit drugs. View study
Interactions between delta9-tetrahydrocannabinol and heroin: self-administration in rhesus monkeys. (2012).
Author(s):Jun-Xu Li* , Wouter Koek, and Charles P. France.
THC does not significantly improve the positive reinforcing effects of heroin, further supporting the view that the combination of cannabinoids and opioid receptor agonists does not increase, and may reduce the abuse of individual drugs. View study
Medical Cannabis Laws and Opioid Analgesic Overdose Mortality in the United States, 1999-2010. (2014).
Author(s):Marcus A. Bachhuber, MD; Brendan Saloner, PhD; Chinazo O. Cunningham, MD, MS; Colleen L. Barry, PhD, MPP.
Based on the results of this study, it was determined that the medical laws on cannabis are associated with significantly lower death rates from opioid overdoses at the state level. Deeper studies are required to determine how medical cannabis laws can interact with policies aimed at preventing overdoses of opioid analgesics. View study